Participants 94 101 3
syncope
Participants 302 391 4
patients with syncope who are at intermediate risk for an adverse cardiovascular outcome.
Participants 759 850 7
One hundred three consecutive patients (53 women; mean age 64+/-17 years) entered the study
Participants 1637 1663 3
intermediate-risk patients
